Colorectal, ovarian and stomach cancer with peritoneal metastasis research hub

Pressurised IntraPeritoneal Aerosolised Chemotherapy (PIPAC) in the management of cancers of the bowel, ovary and stomach: a randomised controlled trial of efficacy in peritoneal metastases

This UK clinical trial is testing a new way to deliver chemotherapy called PIPAC for people whose bowel, ovarian, or stomach cancer has spread to the lining of the abdomen. It aims to see if spraying chemotherapy directly into the tummy during keyhole surgery works better than standard chemotherapy alone.